Biblio

Export 5 results:
Author Keyword Title [ Type(Asc)] Year
Filters: Author is O'Bryant, Sid  [Clear All Filters]
Journal Article
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome., J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., Molecular markers of amnestic mild cognitive impairment among Mexican Americans., J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
G. A. Pathak, Silzer, T. K., Sun, J., Zhou, Z., Daniel, A. A., Johnson, L., O'Bryant, S., Phillips, N. R., and Barber, R. C., Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities., J Alzheimers Dis, vol. 72, no. 3, pp. 733-749, 2019.
M. Petersen, Hall, J., Parsons, T., Johnson, L., and O'Bryant, S., Combining Select Blood-Based Biomarkers with Neuropsychological Assessment to Detect Mild Cognitive Impairment among Mexican Americans., J Alzheimers Dis, vol. 75, no. 3, pp. 739-750, 2020.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies., J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.